Skip to main content

Clinical Trials Using Fluorouracil

Review the clinical trials studying fluorouracil on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 126-150 of 182

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Microsatellite Stable Localized Rectal Cancer before Surgery
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Vactosertib for the Treatment of Patients who are Undergoing Standard of Care Chemoradiation for Locally Advanced Esophageal Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Comparing two Chemotherapy Regimens (NALIRIFOX and mGAP) in the Treatment of Locally Advanced, Unresectable, and Metastatic Pancreatic Adenocarcinoma
Status: Active
Location: Medical University of South Carolina, Charleston, South Carolina
Chemotherapy with or without Radiation or Surgery in Treating Participants with Oligometastatic Esophageal or Gastric Cancer
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Preoperative Hypofractionated Radiotherapy with FOLFOX for the Treatment of Stage I-III Esophageal or Gastroesophageal Junction Adenocarcinoma
Status: Active
Location: 2 locations
Response-Adaptive Chemoradiation after Induction Therapy for the Treatment of Patients with Locally Advanced Head and Neck Squamous Cell Cancer
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
BMS-986504 and Chemotherapy for the Treatment of Resectable, Locally Advanced, Unresectable, or Metastatic, MTAP-Deleted Pancreatic Ducal Adenocarcinoma
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Volrustomig, Paclitaxel, and Carboplatin Followed by Response-Adaptive Treatment in Locally Advanced HPV Megative Head and Neck Squamous Cell Cancer
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Nivolumab, Fluorouracil, and PegInterferon-Alpha2a for the Treatment of Unresectable Fibrolamellar Cancer
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Pegcetacoplan in Combination with Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Status: Active
Location: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
Erlotinib, Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Basal-Like Pancreatic Cancer, PANGEA Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Vasodilator Therapy with Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients with Gastrointestinal Cancer receiving Fluoropyrimidine Therapy
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Fluorouracil with or without Imiquimod for the Treatment of Squamous Cell Carcinoma of the Lower Extremities
Status: Active
Location: UPMC-Saint Margaret, Pittsburgh, Pennsylvania
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Chemotherapy with Radiation for the Treatment of Rectal Cancer
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Zunsemetinib with mFOLFIRINOX for the Treatment of Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Adaptive Radiation Therapy Boost for the Treatment of Rectal Cancer, The ARBOR Trial
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Tislelizumab and Pamiparib in Combination with Concurrent Chemotherapy and Radiation Therapy for the Treatment of Patients with Previously Treated Recurrent Head and Neck Squamous Cell Carcinoma
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
9-ING-41 and Retifanlimab with FOLFIRINOX for the Treatment of Advanced Recurrent or Metastatic Pancreatic Cancer
Status: Active
Location: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania